Dr. Julia Rossié
Biography
Dr. Julia Rossié is a counsel in the Transactional Practice Group of Baker McKenzie in Munich. Her practice spans M&A, venture capital and growth financings, strategic collaborations and licensing transactions. Julia has a particular focus on the life sciences and healthcare sector.
Practice Focus
Julia frequently supports emerging companies throughout their growth journey as well as established life sciences businesses and global pharmaceutical companies on complex transactions and strategic partnerships. Having worked with numerous clients ranging from innovative start-ups to leading international healthcare groups, she brings a broad perspective on the opportunities and challenges across the sector. Julia combines transactional, commercial and industry-specific expertise to support strategic initiatives that drive innovation and growth.
Representative Legal Matters
- Innovative Molecules GmbH on a strategic partnership with Alfasigma S.p.A.
- Keysight Technologies, Inc. on its acquisition of German VPIphotonics
- Takeda in Global Strategic Collaboration with Innovent Biologics bolstering Takeda’s oncology pipeline with next-generation investigational medicines for the treatment of solid tumors.
- icometrix and its shareholders on the sale of icometrix to GE HealthCare.
- Bristol Myers Squibb on the transfer of Juno Therapeutics GmbH to TQ Therapeutics GmbH.
- Astellas in its exclusive option and license agreement with AviadoBio for an investigational gene therapy targeting frontotemporal dementia, including a USD 20 million equity investment and up to USD 30 million in option exercise payments, plus the potential for USD 2.18 billion in license fees and milestone payments plus royalties if Astellas exercises its option.
- Evonik Industries AG on its virtually held annual general meeting.
- Seamless Therapeutics on USD 12.5 million Financing and In-Licensing from TU Dresden.
- Ariceum Therapeutics on a Serie A Financing - co-led by EQT Life Sciences (formerly LSP) and HealthCap - and on an Asset Acquisition from Ipsen Pharma.
- AURELIUS Equity Opportunities SE & Co. KGaA on the sale of its subsidiary GHOTEL hotel & living to the Cologne-based Art-Invest Real Estate Group.
- Hitachi Chemical Company, Ltd., a leading manufacturer of functional materials and advanced components with a strong portfolio in the life sciences industry, on the takeover of German apceth Biopharma, a contract development and manufacturing organization for complex cell-based regenerative gene therapy products.
Admissions
- Germany (2018)
Education
- Higher Regional Court of Hamburg (Assessor Exam)
- University of Munich (Legal Clerk Exam)
- Qingdao University
- University of Salamanca
Languages
- English
- German
- Spanish
Previous Offices
- New York
Baker McKenzie Rechtsanwaltsgesellschaft mbH von Rechtsanwälten und Steuerberatern is registered with the Local Court of Frankfurt/Main (registered seat) HRB 123975. It is associated with Baker & McKenzie International, a Verein organized under the laws of Switzerland.